19.02.2016
- By a vote of ten to five, an advisory panel of the US Food and Drug Administration (FDA) has rejected an application by Merck & Co of the US to widen the indication of its...
17.12.2014
- Bayer's Eylea (VEGF Trap-Eye) is not more effective than its competitor Lucentis to treat patients with diabetic macular edema, the German Institute for Quality and Efficiency in...
29.05.2014
- As expected, Canadian drugmaker Valeant Pharmaceuticals International raised the cash component of its offer for Botox manufacturer Allergan on May 28. Its new offer values the US...
14.01.2014
- Bayer HealthCare of Germany and its U.S. drug development partner Regeneron Pharmaceuticals have agreed to collaborate on Derived Growth Factor Receptor Beta (PDGFR-β) as a...
08.05.2013
- Biotechnology companies that just a short time ago were viewed as takeover targets are now more likely to be buyers themselves after seeing their valuations soar on promising new...
07.05.2013
- Just two years ago, Regeneron Pharmaceuticals was a relatively obscure biotech company in the village of Tarrytown, a picturesque New York suburb better known for "Rip Van Winkle,"...
11.02.2013
- Regeneron Pharmaceuticals said its longtime drug-development partner Sanofi aims to boost its stake in the U.S. biotechnology company through open market purchases of its stock...
14.12.2012
- Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could...
